Obesity and Glucagon-Like Peptide-1 Receptor Agonists (2025)

Table of Contents
JAMA+ Journals Podcasts Citation

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy|Continue

JAMA

    Sign In

    Individual Sign In

    Sign inCreate an Account

    Access through your institution

    Sign In

    Purchase Options:

    Buy this article

    Subscribe to the JAMA journal

    This Issue

    Views 10,102

    Comments 1

    Viewpoint

    December 18, 2024

    FrancescaCelletti,MD, PhD1; FrancescoBranca,MD, PhD1; JeremyFarrar,MD, PhD2

    Author Affiliations Article Information

    • 1Department of Nutrition and Food Safety, World Health Organization, Geneva, Switzerland

    • 2World Health Organization, Geneva, Switzerland

    JAMA. 2025;333(7):561-562. doi:10.1001/jama.2024.25872

    visual abstract icon Visual Abstract editorial comment icon Editorial Comment related articles icon Related Articles author interview icon Interviews multimedia icon Multimedia audio icon Listen to this article

    Full Text

    A new, yet familiar, debate in translational science has erupted. After many years of remarkable advances in basic science, novel therapeutic interventions have emerged, offering the promise of an effective treatment for obesity. Should the world embrace this novel pharmacological solution as the answer to the obesity pandemic? Or should the world be concerned that the medicalization of obesity will dull incentives for healthier lifestyles and allow market forces to perpetuate a profitable cycle of cause and cure?

    Full Text

    Add or change institution

    Comment

    1 Comment for this article

    EXPAND ALL

    December 19, 2024

    Alternative obesity therapy

    Joseph Greene, MD, MBA, FACS, FASMBS | Reston Hospital Center

    As an obesity, treatment, specialist, I agree with Cellenti et al that GLP1-RAs present a revolution in the treatment of obesity, a pandemic which has spread across the globe. I fear that the immediate treatment paradigm presented has neglected an important therapy. Metabolic and Bariatric Surgery has been proven to be the most durable, safe, and effective treatment for obesity in the modern era. Obesity prevention via a healthy lifestyle, including nutrition education and exercise training, as well as mind-body wellness cannot be understated at a population health level. However, multiple studies, including the STAMPEDE trial demonstrated the effectiveness of Roux-en-Y, gastric bypass and sleeve gastrectomy for obesity treatment when compared to lifestyle intervention alone. Additionally, studies of GLP1-RAs, such as SURMOUNT-4 and STEP-4, have shown the temporary effectiveness of these medications only for the duration of administration, but subsequent weight regain once they are stopped. I highlight this data in a non-stigmatizing manner, but only to highlight that lifelong dependence of these medications will be required by patients and health systems, rather than a one time, permanent, solution. A recent study by the group at the University of South Florida in Tampa analyzed the break-even point between the cost of bariatric surgery and GLP1-RAs to be between roughly 12 and 18 months, depending on the medication and procedure choice. It is in this light, that I suggest Metabolic and Bariatric Surgery, be discussed, considered, and implemented in the current treatment paradigm for obesity, until which a long-term prevention and population management strategy can be effectively implemented

    CONFLICT OF INTEREST: Intuitive: Proctor, Stryker: Consultant

    READ MORE

    Read More About

    Obesity Diabetes Diabetes and Endocrinology

    Download PDF Full Text

    Cite This

    Citation

    Celletti F, Branca F, Farrar J. Obesity and Glucagon-Like Peptide-1 Receptor Agonists. JAMA. 2025;333(7):561–562. doi:10.1001/jama.2024.25872

    Manage citations:

    Ris (Zotero) EndNote BibTex Medlars ProCite RefWorks Reference Manager Mendeley

    © 2025

    Comment

    Add or change institution

    JAMA+ AI

    Others Also Liked

    Select Your Interests

    Customize your JAMA Network experience by selecting one or more topics from the list below.

    • Academic Medicine
    • Acid Base, Electrolytes, Fluids
    • Allergy and Clinical Immunology
    • American Indian or Alaska Natives
    • Anesthesiology
    • Anticoagulation
    • Art and Images in Psychiatry
    • Assisted Reproduction
    • Bleeding and Transfusion
    • Cardiology
    • Caring for the Critically Ill Patient
    • Challenges in Clinical Electrocardiography
    • Climate and Health
    • Climate Change
    • Clinical Challenge
    • Clinical Implications of Basic Neuroscience
    • Clinical Pharmacy and Pharmacology
    • Coaching
    • Complementary and Alternative Medicine
    • Consensus Statements
    • Coronavirus (COVID-19)
    • Critical Care Medicine
    • Cultural Competency
    • Dental Medicine
    • Dermatology
    • Diabetes and Endocrinology
    • Diagnostic Test Interpretation
    • Digital Health
    • Drug Development
    • Emergency Medicine
    • End of Life, Hospice, Palliative Care
    • Environmental Health
    • Equity, Diversity, and Inclusion
    • Ethics
    • Facial Plastic Surgery
    • Gastroenterology and Hepatology
    • Genetics and Genomics
    • Genomics and Precision Health
    • Geriatrics
    • Global Health
    • Guide to Statistics and Methods
    • Guidelines
    • Hair Disorders
    • Health Care Delivery Models
    • Health Care Economics, Insurance, Payment
    • Health Care Quality
    • Health Care Reform
    • Health Care Safety
    • Health Care Workforce
    • Health Disparities
    • Health Inequities
    • Health Policy
    • Health Systems Science
    • Hematology
    • History of Medicine
    • Humanities
    • Hypertension
    • Images in Neurology
    • Implementation Science
    • Infectious Diseases
    • Innovations in Health Care Delivery
    • JAMA Forum
    • JAMA Infographic
    • Law and Medicine
    • Leading Change
    • Less is More
    • LGBTQIA Medicine
    • Lifestyle Behaviors
    • Medical Coding
    • Medical Devices and Equipment
    • Medical Education
    • Medical Education and Training
    • Medical Journals and Publishing
    • Melanoma
    • Narrative Medicine
    • Nephrology
    • Neurology
    • Neuroscience and Psychiatry
    • Notable Notes
    • Nursing
    • Nutrition
    • Nutrition, Obesity, Exercise
    • Obesity
    • Obstetrics and Gynecology
    • Occupational Health
    • Oncology
    • Ophthalmology
    • Orthopedics
    • Otolaryngology
    • Pain Medicine
    • Palliative Care
    • Pathology and Laboratory Medicine
    • Patient Care
    • Patient Information
    • Pediatrics
    • Performance Improvement
    • Performance Measures
    • Perioperative Care and Consultation
    • Pharmacoeconomics
    • Pharmacoepidemiology
    • Pharmacogenetics
    • Pharmacy and Clinical Pharmacology
    • Physical Medicine and Rehabilitation
    • Physical Therapy
    • Physician Leadership
    • Poetry
    • Population Health
    • Primary Care
    • Professional Well-being
    • Professionalism
    • Psychiatry and Behavioral Health
    • Public Health
    • Pulmonary Medicine
    • Radiology
    • Regulatory Agencies
    • Reproductive Health
    • Research, Methods, Statistics
    • Resuscitation
    • Rheumatology
    • Risk Management
    • Scientific Discovery and the Future of Medicine
    • Sexual Health
    • Shared Decision Making and Communication
    • Sleep Medicine
    • Sports Medicine
    • Stem Cell Transplantation
    • Substance Use and Addiction Medicine
    • Surgery
    • Surgical Innovation
    • Surgical Pearls
    • Teachable Moment
    • The Art of JAMA
    • The Arts and Medicine
    • The Rational Clinical Examination
    • Tobacco and e-Cigarettes
    • Toxicology
    • Translational Medicine
    • Trauma and Injury
    • Treatment Adherence
    • Ultrasonography
    • Urology
    • Users' Guide to the Medical Literature
    • Vaccination
    • Venous Thromboembolism
    • Veterans Health
    • Violence
    • Women's Health
    • Workflow and Process
    • Wound Care, Infection, Healing

    Save Preferences

    Privacy Policy | Terms of Use

    X

    .

    ×

    Access your subscriptions

    Add or change institution

    Free access to newly published articles

    To register for email alerts, access free PDF, and more

    Purchase access

    Get full journal access for 1 year

    Get unlimited access and a printable PDF ($45.00)—
    Sign in or create a free account

    Rent this article from DeepDyve

    Access your subscriptions

    Add or change institution

    Free access to newly published articles

    To register for email alerts, access free PDF, and more

    Purchase access

    Get full journal access for 1 year

    Get unlimited access and a printable PDF ($45.00)—
    Sign in or create a free account

    Rent this article from DeepDyve

    Sign in to access free PDF

    Add or change institution

    Free access to newly published articles

    To register for email alerts, access free PDF, and more

    Save your search

    Free access to newly published articles

    To register for email alerts, access free PDF, and more

    Purchase access

    Customize your interests

    Free access to newly published articles

    To register for email alerts, access free PDF, and more

    Create a personal account or sign in to:

    • Register for email alerts with links to free full-text articles
    • Access PDFs of free articles
    • Manage your interests
    • Save searches and receive search alerts

      Privacy Policy

      Make a comment

      Free access to newly published articles

      To register for email alerts, access free PDF, and more

      Create a personal account or sign in to:

      • Register for email alerts with links to free full-text articles
      • Access PDFs of free articles
      • Manage your interests
      • Save searches and receive search alerts

        Privacy Policy

        Obesity and Glucagon-Like Peptide-1 Receptor Agonists (2025)
        Top Articles
        Latest Posts
        Recommended Articles
        Article information

        Author: Pres. Lawanda Wiegand

        Last Updated:

        Views: 6464

        Rating: 4 / 5 (71 voted)

        Reviews: 94% of readers found this page helpful

        Author information

        Name: Pres. Lawanda Wiegand

        Birthday: 1993-01-10

        Address: Suite 391 6963 Ullrich Shore, Bellefort, WI 01350-7893

        Phone: +6806610432415

        Job: Dynamic Manufacturing Assistant

        Hobby: amateur radio, Taekwondo, Wood carving, Parkour, Skateboarding, Running, Rafting

        Introduction: My name is Pres. Lawanda Wiegand, I am a inquisitive, helpful, glamorous, cheerful, open, clever, innocent person who loves writing and wants to share my knowledge and understanding with you.